GB0303852D0 - Triazole compounds useful in therapy - Google Patents

Triazole compounds useful in therapy

Info

Publication number: GB0303852D0
Authority: GB; United Kingdom
Prior art keywords: therapy; compounds useful; triazole compounds; triazole; useful
Prior art date: 2003-02-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0303852.8A

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

PFIZER Ltd

Pfizer Ltd Great Britain

Original Assignee

PFIZER Ltd

Pfizer Ltd Great Britain

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-02-19

Filing date

2003-02-19

Publication date

2003-03-26

2003-02-19 Application filed by PFIZER Ltd, Pfizer Ltd Great Britain filed Critical PFIZER Ltd

2003-02-19 Priority to GBGB0303852.8A priority Critical patent/GB0303852D0/en

2003-03-26 Publication of GB0303852D0 publication Critical patent/GB0303852D0/en

2004-02-09 Priority to PT04709303T priority patent/PT1597260E/pt

2004-02-09 Priority to MXPA05008923A priority patent/MXPA05008923A/es

2004-02-09 Priority to PCT/IB2004/000432 priority patent/WO2004074291A1/fr

2004-02-09 Priority to OA1200500229A priority patent/OA13029A/en

2004-02-09 Priority to EA200501136A priority patent/EA009460B1/ru

2004-02-09 Priority to CNA2004800047089A priority patent/CN1751047A/zh

2004-02-09 Priority to AU2004213242A priority patent/AU2004213242B2/en

2004-02-09 Priority to AT04709303T priority patent/ATE349449T1/de

2004-02-09 Priority to HR20050681A priority patent/HRP20050681A2/hr

2004-02-09 Priority to DE602004003914T priority patent/DE602004003914T2/de

2004-02-09 Priority to SI200430160T priority patent/SI1597260T1/sl

2004-02-09 Priority to AP2005003376A priority patent/AP2005003376A0/xx

2004-02-09 Priority to JP2006500323A priority patent/JP4033886B2/ja

2004-02-09 Priority to PL378747A priority patent/PL378747A1/pl

2004-02-09 Priority to GEAP20048945A priority patent/GEP20074089B/en

2004-02-09 Priority to DK04709303T priority patent/DK1597260T3/da

2004-02-09 Priority to RSP-2005/0638A priority patent/RS20050638A/sr

2004-02-09 Priority to KR1020057015408A priority patent/KR100750028B1/ko

2004-02-09 Priority to CA002516557A priority patent/CA2516557C/fr

2004-02-09 Priority to BRPI0407676-1A priority patent/BRPI0407676A/pt

2004-02-09 Priority to ES04709303T priority patent/ES2277237T3/es

2004-02-09 Priority to EP04709303A priority patent/EP1597260B1/fr

2004-02-17 Priority to PE2004000165A priority patent/PE20050222A1/es

2004-02-18 Priority to US10/782,285 priority patent/US7119088B2/en

2004-02-18 Priority to TW093103978A priority patent/TW200500367A/zh

2004-02-18 Priority to ARP040100495A priority patent/AR043210A1/es

2004-02-18 Priority to GT200400020A priority patent/GT200400020A/es

2004-02-18 Priority to PA20048596101A priority patent/PA8596101A1/es

2004-02-18 Priority to CL200400293A priority patent/CL2004000293A1/es

2004-02-19 Priority to NL1025527A priority patent/NL1025527C2/nl

2004-02-19 Priority to UY28201A priority patent/UY28201A1/es

2005-07-25 Priority to IS7957A priority patent/IS2450B/is

2005-08-19 Priority to EC2005005973A priority patent/ECSP055973A/es

2005-08-19 Priority to TNP2005000200A priority patent/TNSN05200A1/fr

2005-08-19 Priority to MA28447A priority patent/MA27712A1/fr

2005-08-31 Priority to NO20054053A priority patent/NO20054053L/no

2006-05-01 Priority to US11/416,498 priority patent/US7442795B2/en

2006-10-11 Priority to JP2006277701A priority patent/JP2007045838A/ja

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Vascular Medicine (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

GBGB0303852.8A 2003-02-19 2003-02-19 Triazole compounds useful in therapy Ceased GB0303852D0 (en)

Priority Applications (39)

Application Number	Priority Date	Filing Date	Title
GBGB0303852.8A GB0303852D0 (en)	2003-02-19	2003-02-19	Triazole compounds useful in therapy
ES04709303T ES2277237T3 (es)	2003-02-19	2004-02-09	Compuestos de triazol utiles en terapia.
KR1020057015408A KR100750028B1 (ko)	2003-02-19	2004-02-09	치료에 유용한 트리아졸 화합물
CA002516557A CA2516557C (fr)	2003-02-19	2004-02-09	Composes de triazole utilises en therapie
PCT/IB2004/000432 WO2004074291A1 (fr)	2003-02-19	2004-02-09	Composes de triazole utilises en therapie
OA1200500229A OA13029A (en)	2003-02-19	2004-02-09	Triazole compounds useful in therapy.
EA200501136A EA009460B1 (ru)	2003-02-19	2004-02-09	Триазольные соединения, полезные в терапии
CNA2004800047089A CN1751047A (zh)	2003-02-19	2004-02-09	可用于治疗的三唑化合物
AU2004213242A AU2004213242B2 (en)	2003-02-19	2004-02-09	Triazole compounds useful in therapy
AT04709303T ATE349449T1 (de)	2003-02-19	2004-02-09	Für die therapie geeignete triazolverbindungen
HR20050681A HRP20050681A2 (en)	2003-02-19	2004-02-09	Triazole compounds useful in therapy
DE602004003914T DE602004003914T2 (de)	2003-02-19	2004-02-09	Für die therapie geeignete triazolverbindungen
SI200430160T SI1597260T1 (sl)	2003-02-19	2004-02-09	Spojine triazola, uporabne pri terapiji
AP2005003376A AP2005003376A0 (en)	2003-02-19	2004-02-09	Triazole compounds useful in therapy.
JP2006500323A JP4033886B2 (ja)	2003-02-19	2004-02-09	治療に有用なトリアゾール化合物
PL378747A PL378747A1 (pl)	2003-02-19	2004-02-09	Związki triazolowe użyteczne w terapii
GEAP20048945A GEP20074089B (en)	2003-02-19	2004-02-09	Triazole compounds useful in therapy
DK04709303T DK1597260T3 (da)	2003-02-19	2004-02-09	Triazol forbindelser, der er anvendelige i behandling
MXPA05008923A MXPA05008923A (es)	2003-02-19	2004-02-09	Compuestos de triazol utiles en terapia.
PT04709303T PT1597260E (pt)	2003-02-19	2004-02-09	Composto de triazole úteis em terapia
BRPI0407676-1A BRPI0407676A (pt)	2003-02-19	2004-02-09	compostos de triazol,uso e processos para fabricação do mesmo
RSP-2005/0638A RS20050638A (sr)	2003-02-19	2004-02-09	Triazolska jedinjenja korisna u terapiji
EP04709303A EP1597260B1 (fr)	2003-02-19	2004-02-09	Composes de triazole utilises en therapie
PE2004000165A PE20050222A1 (es)	2003-02-19	2004-02-17	Compuestos de triazol como antagonistas de vasopresina
CL200400293A CL2004000293A1 (es)	2003-02-19	2004-02-18	Compuestos derivados de dihidrofenantridin-sulfonamidas sustituidas, sus sales; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y su uso en el tratamiento de la diabetes tipo ii, alzheimer, demencia senil, asma, col
US10/782,285 US7119088B2 (en)	2003-02-19	2004-02-18	Triazole compounds useful in therapy
TW093103978A TW200500367A (en)	2003-02-19	2004-02-18	Triazole compounds useful in therapy
ARP040100495A AR043210A1 (es)	2003-02-19	2004-02-18	Compuestos de triazol utiles en terapia
GT200400020A GT200400020A (es)	2003-02-19	2004-02-18	Compuestos de triazol utiles en terapia
PA20048596101A PA8596101A1 (es)	2003-02-19	2004-02-18	Compuestos de triazol utiles en terapia
NL1025527A NL1025527C2 (nl)	2003-02-19	2004-02-19	Triazoolverbindingen die nuttig zijn in therapie.
UY28201A UY28201A1 (es)	2003-02-19	2004-02-19	Compuestos de triazol útiles en terapia
IS7957A IS2450B (is)	2003-02-19	2005-07-25	Tríasól efnasambönd sem eru gagnleg við meðferð
EC2005005973A ECSP055973A (es)	2003-02-19	2005-08-19	Compuestos de triazol utiles en terapia
MA28447A MA27712A1 (fr)	2003-02-19	2005-08-19	Triazoles utiles en therapeutique
TNP2005000200A TNSN05200A1 (fr)	2003-02-19	2005-08-19	Triazoles utiles en therapeutique
NO20054053A NO20054053L (no)	2003-02-19	2005-08-31	Triazolforbindelser anvendbare i terapi.
US11/416,498 US7442795B2 (en)	2003-02-19	2006-05-01	Triazole compounds useful in therapy
JP2006277701A JP2007045838A (ja)	2003-02-19	2006-10-11	治療に有用なトリアゾール化合物

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0303852.8A GB0303852D0 (en)	2003-02-19	2003-02-19	Triazole compounds useful in therapy

Publications (1)

Publication Number	Publication Date
GB0303852D0 true GB0303852D0 (en)	2003-03-26

Family

ID=9953327

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0303852.8A Ceased GB0303852D0 (en)	2003-02-19	2003-02-19	Triazole compounds useful in therapy

Country Status (11)

Country	Link
CN (1)	CN1751047A (fr)
AR (1)	AR043210A1 (fr)
CL (1)	CL2004000293A1 (fr)
GB (1)	GB0303852D0 (fr)
GT (1)	GT200400020A (fr)
NL (1)	NL1025527C2 (fr)
PA (1)	PA8596101A1 (fr)
PE (1)	PE20050222A1 (fr)
TW (1)	TW200500367A (fr)
UY (1)	UY28201A1 (fr)
WO (1)	WO2004074291A1 (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0325021D0 (en) *	2003-10-27	2003-12-03	Pfizer Ltd	Therapeutic combinations
US7745630B2 (en)	2003-12-22	2010-06-29	Justin Stephen Bryans	Triazolyl piperidine arginine vasopressin receptor modulators
DE102004001871A1 (de) *	2004-01-14	2005-09-01	Bayer Healthcare Ag	Tricyclische Benzazepin-Derivate und ihre Verwendung
WO2006021882A1 (fr) *	2004-08-25	2006-03-02	Pfizer Limited	Triazolobenzodiazepines et leur utilisation en tant qu'antagonistes de la vasopressine
EP1877399A1 (fr) *	2005-04-26	2008-01-16	Pfizer Limited	Derives de triazole utilises comme antagonistes de la vasopressine
PL2356123T3 (pl)	2008-11-13	2013-03-29	Hoffmann La Roche	Spiro-5,6-dihudro-4h-2,3,5,10b- tetraazabenzo[e]azuleny
KR101385433B1 (ko) *	2008-11-18	2014-04-14	에프. 호프만-라 로슈 아게	다이하이드로테트라아자벤조아줄렌의 알킬사이클로헥실에터
DK2370441T3 (da)	2008-11-28	2013-10-21	Hoffmann La Roche	Arylcyclohexylethere af dihydrotetraazabenzoazulener til anvendelse som vasopressin v1a-receptorantagonister
US8343961B2 (en)	2009-03-31	2013-01-01	Arqule, Inc.	Substituted heterocyclic compounds
WO2011058193A1 (fr) *	2009-11-16	2011-05-19	Mellitech	Dérivés de [1,5]-diazocine
US8420633B2 (en) *	2010-03-31	2013-04-16	Hoffmann-La Roche Inc.	Aryl-cyclohexyl-tetraazabenzo[e]azulenes
US8461151B2 (en)	2010-04-13	2013-06-11	Hoffmann-La Roche Inc.	Aryl-/heteroaryl-cyclohexenyl-tetraazabenzo[e]azulenes
US8492376B2 (en) *	2010-04-21	2013-07-23	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8481528B2 (en) *	2010-04-26	2013-07-09	Hoffmann-La Roche Inc.	Heterobiaryl-cyclohexyl-tetraazabenzo[e]azulenes
US8513238B2 (en) *	2010-05-10	2013-08-20	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
US9006450B2 (en) *	2010-07-01	2015-04-14	Boehringer Ingelheim International Gmbh	Compounds, pharmaceutical compositions and uses thereof
US8722662B2 (en)	2010-10-07	2014-05-13	Takeda Pharmaceutical Company Limited	Heterocyclic compounds
RU2011122942A (ru)	2011-06-08	2012-12-20	Общество С Ограниченной Ответственностью "Асинэкс Медхим"	Новые ингибиторы киназ
US8828989B2 (en) *	2011-09-26	2014-09-09	Hoffmann-La Roche Inc.	Oxy-cyclohexyl-4H,6H-5-oxa-2,3,10b-triaza-benzo[E]azulenes as V1A antagonists
MX2014003600A (es)	2011-10-05	2014-04-25	Hoffmann La Roche	Ciclohexil-4h,6h-5-oxa-2,3,10b-triaza-benzo[e]azulenos como antagonistas v1a.
PL2861566T3 (pl)	2012-06-13	2017-06-30	F.Hoffmann-La Roche Ag	Nowy diazaspirocykloalkan i azaspirocykloalkan
CN102766674A (zh) *	2012-07-25	2012-11-07	辉源生物科技（上海）有限公司	食蟹猴抗利尿激素受体v1a拮抗剂筛选平台的建立
PL2900669T3 (pl)	2012-09-25	2020-01-31	F. Hoffmann-La Roche Ag	Pochodne heksahydropirolo[3,4-C]pirolu i związki pokrewne jako inhibitory autotaksyny (ATX) oraz inhibitory produkcji kwasu lizofosfatydowego (LPA) do leczenia np. chorób nerek
AR095079A1 (es)	2013-03-12	2015-09-16	Hoffmann La Roche	Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo
CN105492010B (zh)	2013-08-19	2020-01-03	豪夫迈·罗氏有限公司	用于治疗相移睡眠障碍的V1a拮抗剂
HUE036117T2 (hu)	2013-11-26	2018-06-28	Hoffmann La Roche	Oktahidro-ciklobuta[1,2-C;3,4-C']dipirrol származékok, mint autotaxin inhibitorok
HRP20210966T1 (hr)	2013-12-05	2021-09-17	F. Hoffmann - La Roche Ag	Sinteza trans-8-kloro-5-metil-1-[4-(piridin-2-iloksi)-cikloheksil]-5,6-dihidro-4h-2,3,5,10b-tetraazabenzo[e]azulena i njegovih kristalnih oblika
EA037928B1 (ru)	2014-03-26	2021-06-08	Ф. Хоффманн-Ля Рош Аг	Бициклические соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
JP6554481B2 (ja)	2014-03-26	2019-07-31	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	オートタキシン（ａｔｘ）及びリゾホスファチジン酸（ｌｐａ）産生の阻害剤としての縮合［１，４］ジアゼピン化合物
MA41898A (fr)	2015-04-10	2018-02-13	Hoffmann La Roche	Dérivés de quinazolinone bicyclique
CR20180058A (es)	2015-09-04	2018-02-26	Hoffmann La Roche	Nuevos derivados de fenoximetilo
KR20180054830A (ko)	2015-09-24	2018-05-24	에프. 호프만-라 로슈 아게	오토탁신(atx) 억제제로서의 이환형 화합물
CN107922412B (zh)	2015-09-24	2021-02-23	豪夫迈·罗氏有限公司	作为atx抑制剂的二环化合物
EP3353178B1 (fr)	2015-09-24	2021-07-14	F. Hoffmann-La Roche AG	Composés bicycliques comme inhibiteurs mixtes de atx/ca
MX2017015034A (es)	2015-09-24	2018-04-13	Hoffmann La Roche	Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca).
EP3596060B1 (fr)	2017-03-16	2023-09-20	F. Hoffmann-La Roche AG	Nouveaux composés bicycliques utilisés en tant qu'inhibiteurs d'atx
RU2019132254A (ru)	2017-03-16	2021-04-16	Ф. Хоффманн-Ля Рош Аг	Гетероциклические соединения, пригодные в качестве дуальных ингибиторов atx/ca
WO2018226769A1 (fr)	2017-06-05	2018-12-13	Blackthorn Therapeutics, Inc.	Dérivés de 1-(2-azaspiro[3.3]heptan-6-yl)-5,6-dihydro-4h-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazépine en tant qu'antagonistes du récepteur v1a pour le traitement de troubles neuropsychologiques
HU231206B1 (hu) *	2017-12-15	2021-10-28	Richter Gedeon Nyrt.	Triazolobenzazepinek
TW201938171A (zh)	2017-12-15	2019-10-01	匈牙利商羅特格登公司	作為血管升壓素Ｖ１ａ受體拮抗劑之三環化合物
CN111170983B (zh) *	2019-12-26	2021-07-09	中国农业大学	一种苄硫基乙酰胺类化合物及其制备方法与应用
WO2022135335A1 (fr) *	2020-12-21	2022-06-30	上海济煜医药科技有限公司	Dérivé tricyclique de triazole et son procédé de préparation et son application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8823475D0 (en) *	1988-10-06	1988-11-16	Merck Sharp & Dohme	Chemical compounds
US5438035A (en) *	1994-06-24	1995-08-01	American Cyanamid Company	Methods for controlling undesirable plant species with benzodiazepine compounds
US5753648A (en) *	1995-01-17	1998-05-19	American Cyanamid Company	Tricyclic benzazepine vasopressin antagonists
BR9713253A (pt) *	1996-11-01	1999-11-03	American Home Prod	Derivados de 3-carboxamida de 5h-pirrol [2,1-c][1,4]-benzodiazepinas
PL205704B1 (pl) *	1999-01-19	2010-05-31	Ortho Mcneil Pharm Inc	Związki tricyklicznej benzodiazepiny, kompozycja farmaceutyczna zawierająca te związki oraz ich zastosowanie
US7109193B2 (en) *	2001-04-12	2006-09-19	Wyeth	Tricyclic diazepines tocolytic oxytocin receptor antagonists

2003
- 2003-02-19 GB GBGB0303852.8A patent/GB0303852D0/en not_active Ceased
2004
- 2004-02-09 CN CNA2004800047089A patent/CN1751047A/zh active Pending
- 2004-02-09 WO PCT/IB2004/000432 patent/WO2004074291A1/fr not_active Ceased
- 2004-02-17 PE PE2004000165A patent/PE20050222A1/es not_active Application Discontinuation
- 2004-02-18 CL CL200400293A patent/CL2004000293A1/es unknown
- 2004-02-18 AR ARP040100495A patent/AR043210A1/es not_active Application Discontinuation
- 2004-02-18 TW TW093103978A patent/TW200500367A/zh unknown
- 2004-02-18 PA PA20048596101A patent/PA8596101A1/es unknown
- 2004-02-18 GT GT200400020A patent/GT200400020A/es unknown
- 2004-02-19 NL NL1025527A patent/NL1025527C2/nl not_active IP Right Cessation
- 2004-02-19 UY UY28201A patent/UY28201A1/es unknown

Also Published As

Publication number	Publication date
UY28201A1 (es)	2004-09-30
TW200500367A (en)	2005-01-01
CL2004000293A1 (es)	2005-01-07
PA8596101A1 (es)	2005-08-04
GT200400020A (es)	2004-09-21
WO2004074291A1 (fr)	2004-09-02
NL1025527C2 (nl)	2005-03-14
AR043210A1 (es)	2005-07-20
CN1751047A (zh)	2006-03-22
PE20050222A1 (es)	2005-04-13
NL1025527A1 (nl)	2004-08-23

Publication	Publication Date	Title
GB0303852D0 (en)	2003-03-26	Triazole compounds useful in therapy
GB0206033D0 (en)	2002-04-24	Compounds useful in therapy
EP1680114A4 (fr)	2008-09-24	Composes triazole et utilisations associees
GB0416511D0 (en)	2004-08-25	Pyrrolobenzodiazepines
GB0307918D0 (en)	2003-05-14	Therapeutic use
GB0303910D0 (en)	2003-03-26	Therapeutic agents
GB0324761D0 (en)	2003-11-26	Use of compounds in therapy
AU2003212634A8 (en)	2003-09-22	Compounds useful in the treatment of cancer
GB0400700D0 (en)	2004-02-18	Compounds useful in therapy
GB0323258D0 (en)	2003-11-05	Therapeutic compounds
GB0301350D0 (en)	2003-02-19	Therapeutic agents
PL378747A1 (pl)	2006-05-15	Związki triazolowe użyteczne w terapii
GB0329693D0 (en)	2004-01-28	Compounds useful in therapy
GB0319169D0 (en)	2003-09-17	Storage unit
GB0304524D0 (en)	2003-04-02	Therapeutic agents
GB0418980D0 (en)	2004-09-29	Triazole compounds useful in therapy
GB0303289D0 (en)	2003-03-19	Combination therapy
GB0325021D0 (en)	2003-12-03	Therapeutic combinations
GB0401384D0 (en)	2004-02-25	Compounds useful in therapy
GB0307560D0 (en)	2003-05-07	Combination therapy
GB0329512D0 (en)	2004-01-28	Combination therapy
GB0316176D0 (en)	2003-08-13	Combination therapy
GB0316181D0 (en)	2003-08-13	Combination therapy
GB0316184D0 (en)	2003-08-13	Combination therapy
GB0314097D0 (en)	2003-07-23	Combination therapy

Legal Events

Date	Code	Title	Description
2004-05-26	AT	Applications terminated before publication under section 16(1)